Rotterdam Square Event: From Genomic Insight to Diagnostic Impact

After the summer break, on Thursday, September 18, we are excited to come together again at Erasmus MC for an inspiring knowledge session exploring genetic research and diagnostics: ‘From Genomic Insight to Diagnostic Impact’.

This event is a great opportunity to reconnect, exchange ideas, and meet new contacts within the Rotterdam Life Sciences & Health network. Speakers from both research and industry will share their perspectives on the future of genetics and diagnostics and offering valuable insights for everyone in the field.

Date: September 18, 2025
Location: Restaurant Feel Good, Erasmus MC, building Ns-169 – Dr. Molewaterplein 40, 3015 GD Rotterdam

Program 

15:30 – 16:00 – Walk-in

16:00 – 16:05 – Opening & Welcome

16:05 – 17:20 – Presentations

17:20 – 17:25 – Closing

17:25 – 18:30 – Networking & Drinks

Speakers

Prof.Dr. André G. Uitterlinden
Head Laboratory of Population Genomics
Department of Internal Medicine
Erasmus University Medical Center

“Towards using Genetic Information in Health Care and Prevention’’

I’ll take you on a journey through the fast-moving world of DNA analysis – from sequencing an entire human genome in under a day to studying millions of genetic markers across huge populations. Drawing on the European 1 Million Genomes initiative and our GOALL program at Erasmus MC, I’ll show how genetic data is making its way into everyday healthcare to improve diagnosis, treatment, prevention, and screening. Along the way, I’ll share real examples and a glimpse of what’s coming next.

If you would like to see more detailed information, please click here.

Dharminder Chahal MSc
Chief Executive Officer SkylineDx

Dharminder’s presentation will highlight how SkylineDx develops high-value diagnostic products that enable personalized, genomic data-driven care, by improving risk stratification and guiding treatment decisions. It will briefly trace the company’s growth journey and demonstrate how genomic insights are transformed into actionable tools for clinicians. Finally, the presentation will outline SkylineDx’s R&D approach, which accelerates the path from discovery to real-world patient impact.